Ibrutinib in c-MYC and HER2 Amplified Oesophagogastric Carcinoma: Results of the Proof-of-Concept iMYC Study. - Turkes, Fiona; Bryant, Annette; Begum, Ruwaida; Davidson, Michael; Kalaitzaki, Eleftheria; Aresu, Maria; Lazaro-Alcausi, Retchel; Bryant, Jane; Rana, Isma; Chua, Sue; Aronson, Lauren; Hulkki-Wilson, Sanna; et al. (Current Oncology, 2022)